Elizabeth H.z. Thompson - 29 Apr 2021 Form 3 Insider Report for Horizon Therapeutics Public Ltd Co

Role
EVP, Research & Development
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
29 Apr 2021
Net transactions value
$0
Form type
3
Filing time
10 May 2021, 17:00:22 UTC
Next filing
02 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HZNP Ordinary Shares 15,640 29 Apr 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HZNP Restricted Stock Units 29 Apr 2021 Ordinary Shares 12,077 $0.000000 Direct
holding HZNP Restricted Stock Units 29 Apr 2021 Ordinary Shares 2,085 $0.000000 Direct
holding HZNP Restricted Stock Units 29 Apr 2021 Ordinary Shares 14,514 $0.000000 Direct F1
holding HZNP Restricted Stock Units 29 Apr 2021 Ordinary Shares 13,971 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The RSU's vest 50% on each of January 5, 2022 and January 5, 2023.
F2 The RSU's vest 1/3rd annually on each anniversary of January 5, 2021.